Ray, Subrata <br/><br/>
S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Apr 2007 
 - 1368-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-05-0414  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Aphidicolin--pharmacology<br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins<br/>Camptothecin--administration & dosage<br/>Cell Cycle Proteins--metabolism<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1<br/>Checkpoint Kinase 2<br/>DNA-Binding Proteins--metabolism<br/>Down-Regulation--drug effects<br/>Drug Synergism<br/>Enzyme Activation--drug effects<br/>Humans<br/>Irinotecan<br/>Ligands<br/>Male<br/>Mice<br/>Prostatic Neoplasms--drug therapy<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--genetics<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>S Phase--drug effects<br/>TNF-Related Apoptosis-Inducing Ligand--administration & dosage<br/>Transplantation, Heterologous<br/>Tumor Suppressor Proteins--metabolism